Regarding China and Agriculture, here is another relevant

New Post Public Reply Private Reply Replies (0) Message Board
TheSummerMan
310
Regarding China and Agriculture, here is another relevant WSJ article. As you'll read, the State has a pork reserve. So there's a ready buyer for Pangbo's products and the government associations we have discovered should pay off. I don't believe China will let key industries fail, any more than the US will for ours.

From last Saturday's edition.

Emphasis mine.

China’s Inflation Rises at Fastest Pace in Two Years
SINGAPORE—Consumer prices in China rose in September at their fastest annual pace in more than two years, though inflation in the world’s second-largest economy remains mild compared with rates seen in Europe and the U.S.

Annual inflation hit 2.8% in September, China’s National Bureau of Statistics said Friday, driven by a sharp rise in prices of food, especially pork. That compared with a 2.5% annual rise in consumer prices in August, and marked the fastest rate of inflation since April 2020.

Still, economists say inflation in China is likely to ease over the coming months, largely as a result of feeble economic growth.

Data due Friday was expected to have shown that China’s export growth slowed again in September, as rocketing inflation and rising interest rates ate into consumer spending overseas. But as of late Friday evening in China, the figures hadn’t been released. China’s General Administration of Customs offered no explanation and didn’t answer calls seeking comment.

China is due to release gross domestic product figures for the third quarter on Tuesday. The country in the second quarter had registered its weakest growth since the onset of the pandemic, as efforts to contain outbreaks of Covid-19 hit activity in Shanghai and other major cities.

Business surveys and data for July and August suggest the recovery since has been lackluster, with the economy under pressure from a severe real-estate downturn, a summer drought and a collapse in consumer confidence. The global economy is losing steam as the U.S. Federal Reserve and other central banks ratchet up borrowing costs to tame inflation.

The economic headwinds  come as the ruling Chinese Communist Party gathers in Beijing for a congress at which leader Xi Jinping is expected to break with recent precedent and secure a third term in power. Chinese leaders are facing the daunting challenge of fostering a durable revival in China’s economy while solving deeper problems, including big debts, worsening relations with the U.S. and what many economists say is an overreliance on exports and investment to power growth.

The International Monetary Fund this month cut its forecast for growth in China this year and next, citing a darkening backdrop for exports and a worsening real-estate slump. If growth matches its 2022 forecast of 3.2%, compared with a forecast of 3.3% in July, that would represent the worst year for growth in China in four decades, the fund said, excluding 2020 when the effects of the Covid-19 pandemic first struck.

Friday’s data showed inflation in China accelerated on the back of sharply higher pork prices and a pickup in prices for vegetables. Pork prices have been propelled by shortages, and the government has signaled it will release more meat into the market from a state reserve to tame further increases.

Economists polled by The Wall Street Journal had expected annual inflation to accelerate to 2.9% in September, ahead of the 2.8% reading published Friday. Despite the gain, inflation in China remains within the authorities’ goal of keeping consumer-price inflation below 3%, and is well short of the 8.2% annual rate of inflation the U.S. reported for September earlier this week.

Other data reinforced the picture of subdued inflationary pressure in China. Annual producer price inflation, a measure of the prices charged by companies at the factory gate, slowed for the 12th straight month to just 0.9% in September, statistics bureau figures showed.

Economists polled by The Wall Street Journal had expected China’s export growth to slow to 4.0% in September, down from a 7.1% increase in August, reflecting weakening global demand. Imports likely grew 1% from a year earlier, compared with the 0.3% growth in August, according to the poll. That likely put China’s trade surplus at $80 billion last month, slightly wider than $79.4 billion in August.


Energy 1 Corporation (EGOC) Stock Research Links

EGOC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 30

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 22

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 30

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 22

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Quaker Chemical Experiences 52-Week Low Amid Market Challenges

Updated Category News Views 129

Quaker Chemical Faces Significant Market Challenges In a challenging market climate, Quaker Chemical Corporation (NYSE: KWR) recently saw its stock plummet to a 52-week low of $138.97. This specialty chemical company, renowned for its high-performance process fluids and coatings utilized in metalworking, has undergone considerable struggles over the past year, leading to...

Continue Reading
Aura Minerals Completes Significant Bluestone Acquisition

Updated Category News Views 124

Aura Minerals Completes Acquisition of Bluestone Resources Aura Minerals Inc. (TSX: ORA) has successfully executed its acquisition of Bluestone Resources Inc. (BBSRF) through a strategic arrangement. This transaction signals a notable expansion for Aura as it aims to enhance its precious metals portfolio. Terms of the Acquisition Under the recent agreement, shareholders...

Continue Reading
Revolutionizing Employee Benefits with Cutting-Edge Automation

Updated Category News Views 176

Employee Benefits Marketing Transformation In the landscape of employee benefits, there lies a pressing need for innovation, especially regarding effective communication and marketing engagement. Businessolver, a recognized leader in HR and benefits technology, has taken significant strides with the introduction of its Benefits Communication and Automation Engine. This...

Continue Reading
Understanding the Net Asset Value of Middlefield PCC Today

Updated Category News Views 84

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC is a distinct investment option that focuses on providing income opportunities. Established as a protected cell company in Jersey, it adheres to well-defined regulatory standards, adding a layer of security for those who invest in it. Net Asset Value Insights In a recent evaluation, the estimated...

Continue Reading
Tarsus Pharmaceuticals Participates in Healthcare Conference

Updated Category News Views 102

Tarsus Pharmaceuticals Engages in Important Healthcare Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is committed to meeting unmet medical needs through innovative scientific advancements and cutting-edge technology. The company places a strong emphasis on eye care, with the goal of transforming the treatment landscape for patients. Recently, Tarsus announced...

Continue Reading